Yasuda Satoshi, Matsuo Yasuko, Doi Shunsuke, Sakata Takeshi, Nagai Minako, Nakamura Kota, Terai Taichi, Kohara Yuichiro, Sho Masayuki
Department of Surgery, Nara Medical University, 840 Shijo-cho Kashihara-shi, Nara, 634-8522, Japan.
Langenbecks Arch Surg. 2024 Sep 18;409(1):283. doi: 10.1007/s00423-024-03474-x.
Hepatocellular carcinoma (HCC) patients beyond the Milan criteria (MC) who undergo liver resection have high recurrence rates and poor prognosis, and sometimes experience very early recurrence (VER) within six months after surgery. This study aimed to identify predictive factors, including the newly proposed C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index, for VER after surgery for HCC beyond MC.
We included patients who underwent initial liver resection for HCC beyond MC between 2000 and 2021. We defined VER as recurrence within six months after surgery and compared the clinicopathological factors and long-term prognosis between the VER and non-VER groups. Multivariate analysis identified risk factors for VER and evaluated the potential for prognostic stratification using these factors.
The overall survival (OS) and post-recurrence survival were significantly worse in the VER group compared to patients with recurrence in 7-12 months, over 12 months, and without recurrence (median survival time (MST) 1.16 vs. 5.14, 7.26, and undefined; and MST 0.81 vs. 4.34, and 5.48, respectively, P < 0.01). Alpha-fetoprotein (AFP) ≥ 200, non-simple nodule (SN) type on preoperative imaging, and CALLY index < 2.8 were independent prognostic factors (P < 0.01 for all). An increased risk factor count was correlated with poorer VER and OS rates, allowing for effective stratification.
VER after hepatic resection for HCC beyond MC was associated with a significantly poorer prognosis. AFP, non-SN type on imaging, and CALLY index are valuable preoperative indicators. Patients with multiple risk factors have a worse prognosis and may be candidates for multimodal treatment.
米兰标准(MC)以外的肝癌(HCC)患者接受肝切除术,复发率高,预后差,有时在术后 6 个月内出现非常早期复发(VER)。本研究旨在确定预测因素,包括新提出的 C 反应蛋白(CRP)-白蛋白-淋巴细胞(CALLY)指数,以预测 MC 以外 HCC 手术后的 VER。
我们纳入了 2000 年至 2021 年期间接受初始肝切除术治疗 MC 以外 HCC 的患者。我们将 VER 定义为术后 6 个月内复发,并比较 VER 和非 VER 组的临床病理因素和长期预后。多变量分析确定了 VER 的危险因素,并评估了这些因素在预后分层中的潜在价值。
与 7-12 个月、12 个月以上和无复发的患者相比,VER 组的总生存(OS)和复发后生存明显更差(中位生存时间(MST)1.16 对 5.14、7.26 和未定义;MST 0.81 对 4.34 和 5.48,P<0.01)。甲胎蛋白(AFP)≥200、术前影像学非单纯结节(SN)类型和 CALLY 指数<2.8 是独立的预后因素(所有 P<0.01)。危险因素计数的增加与 VER 和 OS 率的降低相关,可有效分层。
MC 以外 HCC 肝切除术后 VER 与预后显著相关。AFP、影像学非 SN 类型和 CALLY 指数是有价值的术前指标。具有多个危险因素的患者预后较差,可能是多模式治疗的候选者。